Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.

about

Knockout of the placenta specific 8 gene radiosensitizes nasopharyngeal carcinoma cells by activating the PI3K/AKT/GSK3β pathway.The role of autophagy in the radiosensitivity of the radioresistant human nasopharyngeal carcinoma cell line CNE-2R

P2860

Q52430636-C259FAF0-7457-4513-94C1-C696B7194F59 Q57484921-A6BA9A03-0840-4BBC-AC75-79A84E38B751

P2860

Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.

Item

http://www.wikidata.org/entity/Q42362640

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Serum CD166: A novel biomarker ...... noma response to radiotherapy.

@en

Serum CD166: A novel biomarker ...... noma response to radiotherapy.

@nl

type

Item

label

Serum CD166: A novel biomarker ...... noma response to radiotherapy.

@en

Serum CD166: A novel biomarker ...... noma response to radiotherapy.

@nl

prefLabel

Serum CD166: A novel biomarker ...... noma response to radiotherapy.

@en

Serum CD166: A novel biomarker ...... noma response to radiotherapy.

@nl

P1476

Serum CD166: A novel biomarker ...... noma response to radiotherapy.

@en

P2093

Fang Su

http://www.w3.org/2001/XMLSchema#string

Huan Lin

http://www.w3.org/2001/XMLSchema#string

Hui-Ling Meng

http://www.w3.org/2001/XMLSchema#string

Jiang-Bo Wu

http://www.w3.org/2001/XMLSchema#string

Jing-Ni Wei

http://www.w3.org/2001/XMLSchema#string

Ling Li

http://www.w3.org/2001/XMLSchema#string

Qi-Yan Mo

http://www.w3.org/2001/XMLSchema#string

Song Qu

http://www.w3.org/2001/XMLSchema#string

Xiao-Dong Zhu

http://www.w3.org/2001/XMLSchema#string

Ze-Tan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term engagement of CD6 and ALCAM is essential for T-cell proliferation induced by dendritic cells

A Review: Proteomics in Nasopharyngeal Carcinoma

Stem cells, colorectal cancer and cancer stem cell markers correlations

Stem cells, cancer, and cancer stem cells

Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma

Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction

ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions

The clonal evolution of tumor cell populations

Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression

Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance

P304

62858-62867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.16399

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28968954

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5609886

http://www.w3.org/2001/XMLSchema#string

Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.

about

P2860

P2860

Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932